EUVIMED · CrossrefZeitschrift
Clinical Parkinsonism & Related Disorders
ISSN 2590-1125 · Elsevier BV
Neueste Artikel
Associations between different dimensions of social cognition and apathy in early-to-moderate-stage Parkinson's disease
Sweating, thermoregulation, and temperature perception following subthalamic deep brain stimulation in Parkinson's disease
Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center
Impact of type 2 diabetes mellitus on acute levodopa responsiveness in Parkinson's disease: A Multicenter retrospective study
Differential effects of dopaminergic medication and subthalamic deep brain stimulation on gait in Parkinson's disease: A two-case report
Pallidal deep brain stimulation for Parkinson's disease: indications for target selection and perceived outcomes at two centers
Benchmarking general and medical LLM performance in Parkinson's disease management
Differentiation of PD, MSA and PSP using clinical data from the prospective AIDP cohort
Non-motor outcomes and divergent plasma metabolite changes during continuous subcutaneous foslevodopa/foscarbidopa infusion in Parkinson's disease
Cognitive load and mobility: Within-session repeatability and preliminary group discrimination of a dual-task 10-Meter Walk Test with Stroop in Parkinson's disease
Psychosocial and motor impact of Puerto Rican Salsa in Parkinson’s disease: a mixed-methods preliminary study
Foslevodopa/Foscarbidopa in advanced Parkinson's disease: One-year continuation
Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson’s disease
Efficacy of virtual reality-based cognitive behavioral group therapy in enhancing emotional well-being and quality of life in Parkinson’s disease: A randomized controlled trial
Dopa-responsive parkinsonism without cerebellar ataxia in spinocerebellar ataxia 6
Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease
Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN
Movement disorders accompanying lithium intoxication – An evolving clinical presentation and SILENT syndrome
Distinctive cognitive phenotypes in Parkinson’s disease patients with GBA mutations and without dementia: a multicentre cross-sectional retrospective study
Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson’s disease. A case series and literature review
Effects of the continuous subcutaneous infusion of foslevodopa-foscarbidopa on swallowing in patients with Parkinson’s disease
Effects of dopaminergic medication on upper limb motor function, strength and hand dexterity in people with Parkinson’s disease
A meta-analysis of the long-term efficacy of Amantadine for Levodopa-induced dyskinesia in Parkinson’s disease
Meaning in life and Parkinson’s disease in the UK Biobank
Overview of management of infection-related movement disorders with focus on specific-infections
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance
Self-treatment of freezing of gait in Parkinson’s disease patients using silicone pads to apply Thai acupressure to plantar acupoints: A randomised, controlled trial
Too little or too much nocturnal movements in Parkinson’s disease: A practical guide to managing the unseen
How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature
Successful implementation of technology in the management of Parkinson's disease: Barriers and facilitators
EUVIMED